Aytu Biopharma, Inc.
AYTU
$2.18
$0.010.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.32% | -10.91% | 1.44% | 0.51% | 1.24% |
| Total Receivables | -13.04% | 41.03% | 9.69% | -1.56% | -21.38% |
| Inventory | 3.40% | -0.24% | -5.57% | -3.31% | -7.97% |
| Prepaid Expenses | -24.38% | 20.90% | 7.59% | 12.46% | -29.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 11.76% |
| Total Current Assets | 9.19% | 15.00% | 3.81% | -1.86% | -12.99% |
|
|
|||||
| Total Current Assets | 9.19% | 15.00% | 3.81% | -1.86% | -12.99% |
| Net Property, Plant & Equipment | -3.86% | -2.18% | -11.63% | 25.95% | -44.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.36% | -2.50% | -2.44% | -2.38% | -3.01% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.86% | -13.21% | -22.78% | -11.57% | 150.73% |
| Total Assets | -0.02% | 6.86% | 0.34% | -1.92% | -8.36% |
|
|
|||||
| Total Accounts Payable | -11.96% | 2.92% | -13.42% | 31.02% | -1.54% |
| Total Accrued Expenses | -13.66% | -10.52% | 0.91% | -12.05% | -2.44% |
| Short-term Debt | -9.62% | 149.95% | -6.04% | 78.29% | 51.49% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.79% | -3.92% | -12.90% | -8.88% | -84.21% |
| Total Finance Division Other Current Liabilities | -9.85% | 9.26% | 23.16% | -12.72% | -24.14% |
| Total Other Current Liabilities | -9.85% | 9.26% | 23.16% | -12.72% | -24.14% |
| Total Current Liabilities | -10.81% | 10.40% | 4.56% | -1.57% | -25.64% |
|
|
|||||
| Total Current Liabilities | -10.81% | 10.40% | 4.56% | -1.57% | -25.64% |
| Long-Term Debt | 14.26% | -4.49% | -4.29% | -4.11% | -- |
| Short-term Debt | -9.62% | 149.95% | -6.04% | 78.29% | 51.49% |
| Capital Leases | -1.60% | -9.49% | -3.32% | 98.27% | -26.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 275.47% | -21.93% | -21.66% | -21.07% | 22.65% |
| Total Liabilities | 17.81% | 4.49% | -0.63% | -4.84% | -7.86% |
|
|
|||||
| Common Stock & APIC | 1.11% | 0.04% | 0.04% | 0.18% | 0.45% |
| Retained Earnings | -6.32% | 1.26% | 0.25% | 0.46% | -1.46% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -45.65% | 13.43% | 3.15% | 7.61% | -9.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.65% | 13.43% | 3.15% | 7.61% | -9.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.65% | 13.43% | 3.15% | 7.61% | -9.95% |
|
|
|||||